Cargando…

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis

BACKGROUND: Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is characterised by severe prolonged fatigue, and decreases in cognition and other physiological functions, resulting in severe loss of quality of life, difficult clinical management and high costs to the health care system. To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brenu, Ekua W, van Driel, Mieke L, Staines, Don R, Ashton, Kevin J, Ramos, Sandra B, Keane, James, Klimas, Nancy G, Marshall-Gradisnik, Sonya M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120691/ https://www.ncbi.nlm.nih.gov/pubmed/21619669 http://dx.doi.org/10.1186/1479-5876-9-81

Ejemplares similares

The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis
por: Johnston, Samantha, et al.
Publicado: (2013)

Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis
por: Brenu, Ekua W, et al.
Publicado: (2012)

Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
por: Hardcastle, Sharni Lee, et al.
Publicado: (2015)

High-Throughput Sequencing of Plasma MicroRNA in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Brenu, Ekua W., et al.
Publicado: (2014)

A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis
por: Brenu, Ekua W., et al.
Publicado: (2016)

Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
por: Hardcastle, Sharni Lee, et al.
Publicado: (2015)

Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
por: Hardcastle, Sharni Lee, et al.
Publicado: (2015)

A comparison of health status in patients meeting alternative definitions for chronic fatigue syndrome/myalgic encephalomyelitis
por: Johnston, Samantha C, et al.
Publicado: (2014)

Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Peterson, D., et al.
Publicado: (2015)

The Economic Impacts of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in an Australian Cohort
por: Close, Shara, et al.
Publicado: (2020)

Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients
por: Johnston, Samantha C, et al.
Publicado: (2016)

Alteration of Cortical Volume and Thickness in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2022)

A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease
por: Holden, Sean, et al.
Publicado: (2020)

Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Maksoud, Rebekah, et al.
Publicado: (2021)

Diffusion tensor imaging reveals neuronal microstructural changes in myalgic encephalomyelitis/chronic fatigue syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2021)

Correction to: A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease
por: Holden, Sean, et al.
Publicado: (2020)

Postulated vasoactive neuropeptide immunopathology affecting the blood–brain/blood–spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?
por: Staines, Donald R, et al.
Publicado: (2009)

Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients
por: Balinas, Cassandra, et al.
Publicado: (2019)

Volumetric differences in hippocampal subfields and associations with clinical measures in myalgic encephalomyelitis/chronic fatigue syndrome
por: Thapaliya, Kiran, et al.
Publicado: (2022)

Killer Cell Immunoglobulin-like Receptor Genotype and Haplotype Investigation of Natural Killer Cells from an Australian Population of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
por: Huth, T. K., et al.
Publicado: (2016)

Impact of Life Stressors on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symptoms: An Australian Longitudinal Study
por: Balinas, Cassandra, et al.
Publicado: (2021)

A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome
por: Maksoud, Rebekah, et al.
Publicado: (2021)

Immune and hemorheological changes in Chronic Fatigue Syndrome
por: Brenu, Ekua W, et al.
Publicado: (2010)

Dysregulation of Protein Kinase Gene Expression in NK Cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients
por: Chacko, Anu, et al.
Publicado: (2016)

Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review
por: Du Preez, Stanley, et al.
Publicado: (2021)

A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome
por: Eaton-Fitch, Natalie, et al.
Publicado: (2019)

A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis
por: Du Preez, S., et al.
Publicado: (2018)

A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID)
por: Corbitt, Matthew, et al.
Publicado: (2019)

A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID)
por: Huth, Teilah Kathryn, et al.
Publicado: (2020)

Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy?
por: Staines, Donald R, et al.
Publicado: (2009)

Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome
por: Marshall-Gradisnik, Sonya, et al.
Publicado: (2016)

Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation
por: Eaton, Natalie, et al.
Publicado: (2018)

A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Johnston, Samantha, et al.
Publicado: (2016)

Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review
por: Campagnolo, N., et al.
Publicado: (2017)

A systematic review of neurological impairments in myalgic encephalomyelitis/ chronic fatigue syndrome using neuroimaging techniques
por: Maksoud, Rebekah, et al.
Publicado: (2020)

Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Cabanas, Helene, et al.
Publicado: (2019)

Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study
por: Słomko, Joanna, et al.
Publicado: (2019)

Brainstem volume changes in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID patients
por: Thapaliya, Kiran, et al.
Publicado: (2023)

Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review
por: Maksoud, Rebekah, et al.
Publicado: (2023)

A preliminary investigation of nutritional intake and supplement use in Australians with myalgic encephalomyelitis/chronic fatigue syndrome and the implications on health-related quality of life
por: Weigel, Breanna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4dl8bnlelqfmai4pcu6c1rcdfn